HomeTERN • NASDAQ
add
Terns Pharmaceuticals Inc
Previous close
$6.14
Day range
$5.85 - $6.12
Year range
$3.26 - $13.03
Market cap
381.58M USD
Avg Volume
768.15K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 25.45M | 5.34% |
Net income | -22.37M | -3.93% |
Net profit margin | — | — |
Earnings per share | -0.30 | 3.23% |
EBITDA | -25.37M | -5.37% |
Effective tax rate | -0.44% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 263.44M | -11.46% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 255.37M | — |
Shares outstanding | 64.65M | — |
Price to book | 1.55 | — |
Return on assets | — | — |
Return on capital | -24.85% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -22.37M | -3.93% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2016
Headquarters
Website
Employees
66